The Global BioAccess Fund is a venture capital investment firm that focuses on investing in companies developing novel therapeutics and devices to address serious unmet medical needs in areas such as oncology, rare diseases, CNS, and cardiovascular conditions. Founded in 2021 and based in New York, the fund supports early-stage companies requiring capital for IND submission and clinical trials.
Focus Areas
Investment Types
Notable Investments
